In fiscal year 2019, the leading product in terms of sales of the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd. was Entyvio, with a sales value of more than 347 billion Japanese yen. Entyvio is a prescription drug treating adult patients with ulcerative colitis and Crohn's disease.
Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2019 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Takeda Pharmaceutical's number of employees FY 2012-2019
- Takeda Pharmaceutical's net income FY 2012-2019
- Takeda Pharmaceutical's total assets FY 2012-2019
- Takeda Pharmaceutical's expenditure on R&D FY 2011-2019
- Takeda Pharmaceutical's revenue in FY 2016, by segment
- Takeda Pharmaceutical's revenue breakdown FY 2019, by region
- Italy: percent change in pharmaceutical sales volume by type of drug 2016
- Revenue of Lundbeck top products 2020
- Share of global immunoglobulin therapies market 2017, by country
- Leading pharmaceutical companies in Italy 2018, by revenues
- Revenue of leading hundred pharmaceutical products by region 2012
Takeda Pharmaceutical Company. (October 29, 2020). Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2019 (in billion Japanese yen) [Graph]. In Statista. Retrieved February 28, 2021, from https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. "Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2019 (in billion Japanese yen)." Chart. October 29, 2020. Statista. Accessed February 28, 2021. https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. (2020). Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2019 (in billion Japanese yen). Statista. Statista Inc.. Accessed: February 28, 2021. https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. "Global Major Products' Sales Revenue of Takeda Pharmaceutical Co., Ltd. in Fiscal Year 2019 (in Billion Japanese Yen)." Statista, Statista Inc., 29 Oct 2020, https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company, Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2019 (in billion Japanese yen) Statista, https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/ (last visited February 28, 2021)